Pharmacology & ToxicologybioRxiv
Beta2 -Adrenergic Agonists in Treatment for Parkinsonism, with Implications for Neurodegenerative and Neoplastic Disorders.
This paper investigates the therapeutic potential of beta2-adrenergic agonists, particularly levalbuterol, in Parkinsonism and other disorders by examining their anti-inflammatory and anti-tumor effects.
DOI 10.3390/biomedicines12081720